Center for Reproductive Health Research Studies

If you are unsure about what studies you qualify for, simply email us at [email protected]. Alternatively, explore different UCSF studies at clinicaltrials.ucsf.edu

I'm interested in participating!

Fertility Preservation Studies

BRIOR Study | Impact of Local Radiotherapy to the Breast on Ovarian Reserve in Premenopausal Women with Early-Stage Breast Cancer

Status: Active, Enrolling
This study aims to prospectively assess the impact of distant effects from breast radiation on ovarian reserve. We will determine ovarian reserve through blood measurements of Anti-Müllerian Hormone (AMH), a relatively new and reliable serum biomarker of ovarian reserve that has already been incorporated into the standard practice of reproductive endocrinology and infertility.

You may be eligible if you are: female (or assigned female at birth), aged 18-45, and diagnosed with in-situ breast cancer or stage 1 breast cancer

Nik Lenhart
Clinical Research Coordinator
415-502-2555
[email protected]

Mitchell Rosen MD HCLD
Principal Investigator


TALES Trial | Fertility Preservation using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial

Status: Active, Enrolling
Letrozole plus gonadotropin, and Tamoxifen plus gonadotropin, are two methods currently used worldwide in ovarian stimulation cycles for fertility preservation in patients with estrogen-receptor-positive breast cancer. Improved knowledge about the efficacy of these medications, with regard to oocyte yield, has the potential to significantly improve quality of life in reproductive-age breast cancer survivors.

You may be eligible if you are: female (or assigned female at birth), aged 18 years and older, diagnosed with breast cancer and not currently receiving chemotherapy

Nik Lenhart
Clinical Research Coordinator
415-502-2555
[email protected]

Mitchell Rosen MD HCLD
Principal Investigator

clinical trials Website